256 related articles for article (PubMed ID: 23687338)
1. Tumor MMP-1 activates endothelial PAR1 to facilitate vascular intravasation and metastatic dissemination.
Juncker-Jensen A; Deryugina EI; Rimann I; Zajac E; Kupriyanova TA; Engelholm LH; Quigley JP
Cancer Res; 2013 Jul; 73(14):4196-211. PubMed ID: 23687338
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of metastasis variants derived from human prostate carcinoma cells: roles in intravasation of VEGF-mediated angiogenesis and uPA-mediated invasion.
Conn EM; Botkjaer KA; Kupriyanova TA; Andreasen PA; Deryugina EI; Quigley JP
Am J Pathol; 2009 Oct; 175(4):1638-52. PubMed ID: 19729488
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of matrix metalloproteinases and tissue inhibitors of metalloproteinases differentially expressed by variants of human HT-1080 fibrosarcoma exhibiting high and low levels of intravasation and metastasis.
Partridge JJ; Madsen MA; Ardi VC; Papagiannakopoulos T; Kupriyanova TA; Quigley JP; Deryugina EI
J Biol Chem; 2007 Dec; 282(49):35964-77. PubMed ID: 17895241
[TBL] [Abstract][Full Text] [Related]
4. Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination.
Deryugina EI; Zijlstra A; Partridge JJ; Kupriyanova TA; Madsen MA; Papagiannakopoulos T; Quigley JP
Cancer Res; 2005 Dec; 65(23):10959-69. PubMed ID: 16322244
[TBL] [Abstract][Full Text] [Related]
5. Chorioallantoic Membrane Microtumor Model to Study the Mechanisms of Tumor Angiogenesis, Vascular Permeability, and Tumor Cell Intravasation.
Deryugina EI
Methods Mol Biol; 2016; 1430():283-98. PubMed ID: 27172961
[TBL] [Abstract][Full Text] [Related]
6. EGFR regulates the development and microarchitecture of intratumoral angiogenic vasculature capable of sustaining cancer cell intravasation.
Minder P; Zajac E; Quigley JP; Deryugina EI
Neoplasia; 2015 Aug; 17(8):634-49. PubMed ID: 26408256
[TBL] [Abstract][Full Text] [Related]
7. Activation of pro-uPA is critical for initial escape from the primary tumor and hematogenous dissemination of human carcinoma cells.
Bekes EM; Deryugina EI; Kupriyanova TA; Zajac E; Botkjaer KA; Andreasen PA; Quigley JP
Neoplasia; 2011 Sep; 13(9):806-21. PubMed ID: 21969814
[TBL] [Abstract][Full Text] [Related]
8. LTBP3 promotes early metastatic events during cancer cell dissemination.
Deryugina EI; Zajac E; Zilberberg L; Muramatsu T; Joshi G; Dabovic B; Rifkin D; Quigley JP
Oncogene; 2018 Apr; 37(14):1815-1829. PubMed ID: 29348457
[TBL] [Abstract][Full Text] [Related]
9. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.
Boire A; Covic L; Agarwal A; Jacques S; Sherifi S; Kuliopulos A
Cell; 2005 Feb; 120(3):303-13. PubMed ID: 15707890
[TBL] [Abstract][Full Text] [Related]
10. A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in sepsis.
Tressel SL; Kaneider NC; Kasuda S; Foley C; Koukos G; Austin K; Agarwal A; Covic L; Opal SM; Kuliopulos A
EMBO Mol Med; 2011 Jul; 3(7):370-84. PubMed ID: 21591259
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1).
Kim SJ; Shin JY; Lee KD; Bae YK; Choi IJ; Park SH; Chun KH
PLoS One; 2011; 6(9):e25103. PubMed ID: 21966428
[TBL] [Abstract][Full Text] [Related]
12. Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT.
Zhu Y; Tao Z; Chen Y; Lin S; Zhu M; Ji W; Liu X; Li T; Hu X
Breast Cancer Res Treat; 2022 May; 193(1):65-81. PubMed ID: 35254603
[TBL] [Abstract][Full Text] [Related]
13. Activity-based protein profiling implicates urokinase activation as a key step in human fibrosarcoma intravasation.
Madsen MA; Deryugina EI; Niessen S; Cravatt BF; Quigley JP
J Biol Chem; 2006 Jun; 281(23):15997-6005. PubMed ID: 16611636
[TBL] [Abstract][Full Text] [Related]
14. Noncanonical matrix metalloprotease-1-protease-activated receptor-1 signaling triggers vascular smooth muscle cell dedifferentiation and arterial stenosis.
Austin KM; Nguyen N; Javid G; Covic L; Kuliopulos A
J Biol Chem; 2013 Aug; 288(32):23105-15. PubMed ID: 23814055
[TBL] [Abstract][Full Text] [Related]
15. MMP-1-PAR1 axis mediates LPA-induced epithelial ovarian cancer (EOC) invasion.
Wang FQ; Fisher J; Fishman DA
Gynecol Oncol; 2011 Feb; 120(2):247-55. PubMed ID: 21093894
[TBL] [Abstract][Full Text] [Related]
16. NF-κB contributes to MMP1 expression in breast cancer spheroids causing paracrine PAR1 activation and disintegrations in the lymph endothelial barrier in vitro.
Nguyen CH; Senfter D; Basilio J; Holzner S; Stadler S; Krieger S; Huttary N; Milovanovic D; Viola K; Simonitsch-Klupp I; Jäger W; de Martin R; Krupitza G
Oncotarget; 2015 Nov; 6(36):39262-75. PubMed ID: 26513020
[TBL] [Abstract][Full Text] [Related]
17. Cell surface proteomics identifies molecules functionally linked to tumor cell intravasation.
Conn EM; Madsen MA; Cravatt BF; Ruf W; Deryugina EI; Quigley JP
J Biol Chem; 2008 Sep; 283(39):26518-27. PubMed ID: 18658134
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-1 and thrombin differentially activate gene expression in endothelial cells via PAR-1 and promote angiogenesis.
Blackburn JS; Brinckerhoff CE
Am J Pathol; 2008 Dec; 173(6):1736-46. PubMed ID: 18988801
[TBL] [Abstract][Full Text] [Related]
19. Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation.
Bekes EM; Schweighofer B; Kupriyanova TA; Zajac E; Ardi VC; Quigley JP; Deryugina EI
Am J Pathol; 2011 Sep; 179(3):1455-70. PubMed ID: 21741942
[TBL] [Abstract][Full Text] [Related]
20. BMX Represses Thrombin-PAR1-Mediated Endothelial Permeability and Vascular Leakage During Early Sepsis.
Li Z; Yin M; Zhang H; Ni W; Pierce RW; Zhou HJ; Min W
Circ Res; 2020 Feb; 126(4):471-485. PubMed ID: 31910739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]